Market Overview

A Peek Into The Market Before The Trading Starts

Related ACN
Stocks Mildly Higher To End The Week
Morgan Stanley Updates Forecast For Accenture PLC
Accenture 2Q Profit Slumps, Misses Street View (Fox Business)
Related GRPN
NASDAQ Sees Selloff After Recent Bull Run
UPDATE: B. Riley & Co. Upgrades Groupon
Yodle Faces Hurdles in Bid to Conquer Local Ad Market (Fox Business)

Pre-open movers US stock futures are higher this morning, as investors are awaiting retail sales data. Futures for the Dow Jones Industrial Average surged 24 points to 13,161.00 and S&P 500 index futures rose 2.40 points to 1,405.00. Nasdaq 100 futures gained 4 points to 2,732.00.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index gained 0.43%, French CAC 40 index rose 0.28%. London's FTSE 100 Index moved up 0.48% and German DAX 30 index rose 0.82%.

Asian markets ended higher, with Japan's Nikkei Stock Average gaining 0.50%, China's Shanghai Composite rising 0.30% and Australia's S&P/ASX 200 moving up 0.18%. Hong Kong's Hang Seng index surged 1.05% and India's Sensex gained 0.56%.

Broker Recommendation Analysts at Citigroup downgraded Groupon (NASDAQ: GRPN) from “buy” to “neutral.” The target price for Groupon has been lowered from $19 to $9.

Groupon shares dropped 18.68% to $6.14 in pre-market trading.

Breaking news

  • Towers Watson and Co (NYSE: TW) posted a better-than-expected fourth-quarter profit. However, the company issued a weak Q1 forecast. To read the full news, click here.
  • The U.S. Office of the Deputy Assistant Secretary of Defense has awarded Accenture Federal Services a two-year contract to identify ways that will improve forecasting techniques throughout the U.S. Department of Defense (DOD). To read the full news, click here.
  • Arrowhead Research (NASDAQ: ARWR) today announced that it entered into an agreement with Merck, through a subsidiary, to undertake an evaluation of a novel proprietary therapeutic monoclonal antibody candidate derived from Arrowhead's human-derived peptide targeting and discovery program. To read the full news, click here.
  • CONMED (NASDAQ: CNMD) and Viking Systems (OTC: VKNG) today announced that the companies have entered into a definitive agreement providing for CONMED to acquire Viking for $0.27 per share in cash. To read the full news, click here.

Posted-In: Citigroup US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Most Popular

Related Articles (ARWR + ACN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free